5-HTP

Last Updated: June 25, 2024

5-HTP is the precursor to serotonin, a neurotransmitter involved in regulating many body processes like mood, sleep, and appetite. 5-HTP can increase levels of serotonin in the brain, which may reduce symptoms of depression and reduce appetite.

5-HTP is most often used for

What is 5-HTP?

5-HTP is an amino acid that serves as a precursor to serotonin and is produced in the body from tryptophan. It can be supplemented directly, and Griffonia simplicifolia seeds are a common source for its extraction.

What are 5-HTP’s main benefits?

5-HTP is primarily known for its potential to increase serotonin levels in the brain, which may help alleviate symptoms of depression and aid in appetite regulation, particularly in people with obesity. However, although some studies suggest it may be effective, the overall evidence is weak, and more rigorous research is needed to confirm these benefits.

What are 5-HTP’s main drawbacks?

5-HTP can cause mild side effects such as nausea, abdominal pain, and diarrhea, and more serious effects like confusion and memory impairment are reported with intravenous use. Additionally, high doses may lead to serotonin syndrome in lab animals, and although there have been rare cases of eosinophilia myalgia syndrome associated with 5-HTP, these are associated with contaminants in supplements rather than the compound itself.

How does 5-HTP work?

5-HTP serves as a direct precursor to serotonin and crosses the blood-brain barrier to potentially increase serotonin levels in the brain, which may influence mood, sleep, appetite, and memory. However, the connection between serotonin levels and depression is complex and not definitively established.

What are other names for 5-HTP?
Note that 5-HTP is also known as:
  • 5-hydroxytryptophan
  • L-5-Hydroxytryptophan
  • L-5HTP
  • Oxitriptan
5-HTP should not be confused with:
Dosage information

5-HTP is usually taken orally in capsule form. It can be taken once daily or in divided doses (i.e., the total daily dose is split into two or three doses).

For depression, most studies have used dosages in the range of 200 mg to 300 mg daily for up to 1 year.[1]

For weight loss or appetite regulation, 5-HTP has been used in the range of 750 mg to 900 mg daily for up to 6 weeks.[2][3]

Supplements Demystified: Get Our Unbiased, Evidence-Based Guide

Examine Database: 5-HTP
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

Update History
2024-06-25 00:30:03

Three studies added to database

minor

We added 3 RCTs on 5-HTP to the Examine database. Altogether, they suggest that 5-HTP may be beneficial for depressive symptoms in people with depression, but not necessarily in people with Parkinson's.

Written By

Reviewed By

2024-06-12 00:30:04

Full page update

major

We updated the following FAQs:

What are 5-HTP's main benefits?: We added more details on the benefits of 5-HTP, as well as research limitations. Reducing symptoms of depression and promoting weight loss through appetite regulation remain the main potential benefits of 5-HTP. We removed sleep from this section due to unclear evidence of a benefit and potentially negative effects on sleep. Parkinson's disease, headache prevention, and fibromyalgia were added as areas of interest with a currently inconclusive and mixed evidence base.

What are 5-HTP's main drawbacks?: We added information about possible side effects with 5-HTP, the most common being nausea, abdominal pain, and diarrhea. We discussed the connection between 5-HTP and eosinophilia myalgia syndrome which was likely due to a toxic contaminant in the supplements and has not been observed in recent years.

Does 5-HTP affect sleep?: We added an FAQ to discuss the research on 5-HTP and sleep. Currently, no consistent benefit on sleep has been observed and some studies have reported increased rates of nightmares or reduced sleep duration.

Is tryptophan supplementation a suitable alternative to 5-HTP?: We added an FAQ to discuss whether tryptophan can be taken in place of 5-HTP. 5-HTP is a more reliable way of increasing serotonin levels than tryptophan because it crosses the blood-brain barrier more easily, requires less steps for serotonin synthesis, and has less alternative uses in the body.

Written By

Reviewed By

References
  1. ^Erick H Turner, Jennifer M Loftis, Aaron D BlackwellSerotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophanPharmacol Ther.(2006 Mar)
  2. ^Cangiano C, Laviano A, Del Ben M, Preziosa I, Angelico F, Cascino A, Rossi-Fanelli FEffects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patientsInt J Obes Relat Metab Disord.(1998 Jul)
  3. ^Cangiano C, Ceci F, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Antonucci F, Rossi-Fanelli FEating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophanAm J Clin Nutr.(1992 Nov)
  4. ^Maffei ME5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology.Int J Mol Sci.(2020-Dec-26)
  5. ^O'Neil MF, Moore NAAnimal models of depression: are there any?Hum Psychopharmacol.(2003 Jun)
  6. ^Moncrieff J, Cooper RE, Stockmann T, Amendola S, Hengartner MP, Horowitz MAThe serotonin theory of depression: a systematic umbrella review of the evidence.Mol Psychiatry.(2023-Aug)
  7. ^Shaw K, Turner J, Del Mar CAre tryptophan and 5-hydroxytryptophan effective treatments for depression? A meta-analysis.Aust N Z J Psychiatry.(2002 Aug)
  8. ^Jangid P, Malik P, Singh P, Sharma M, Gulia AKComparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.Asian J Psychiatr.(2013-Feb)
  9. ^Pöldinger W, Calanchini B, Schwarz WA functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.Psychopathology.(1991)
  10. ^Ceci F, Cangiano C, Cairella M, Cascino A, Del Ben M, Muscaritoli M, Sibilia L, Rossi Fanelli FThe effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjectsJ Neural Transm.(1989)
  11. ^Ribeiro CAL-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebo-controlled study. For the Portuguese Head Society.Headache.(2000 Jun)
  12. ^De Benedittis G, Massei RSerotonin precursors in chronic primary headache. A double-blind cross-over study with L-5-hydroxytryptophan vs. placebo.J Neurosurg Sci.(1985 Jul-Sep)
  13. ^Titus F, Dávalos A, Alom J, Codina A5-Hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomized clinical trial.Eur Neurol.(1986)
  14. ^Caruso I, Sarzi Puttini P, Cazzola M, Azzolini VDouble-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome.J Int Med Res.(1990 May-Jun)
  15. ^Sarzi Puttini P, Caruso IPrimary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study.J Int Med Res.(1992 Apr)
  16. ^Meloni M, Puligheddu M, Sanna F, Cannas A, Farris R, Tronci E, Figorilli M, Defazio G, Carta MEfficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding.J Neurol Sci.(2020 Aug 15)
  17. ^Chase TN, Ng LK, Watanabe AMParkinson's disease. Modification by 5-hydroxytryptophan.Neurology.(1972 May)
  18. ^Javelle F, Lampit A, Bloch W, Häussermann P, Johnson SL, Zimmer PEffects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis.Nutr Rev.(2020 Jan 1)
  19. ^Das YT, Bagchi M, Bagchi D, Preuss HGSafety of 5-hydroxy-L-tryptophan.Toxicol Lett.(2004 Apr 15)
  20. ^Wyatt RJ, Zarcone V, Engelman K, Dement WC, Snyder F, Sjoerdsma AEffects of 5-hydroxytryptophan on the sleep of normal human subjects.Electroencephalogr Clin Neurophysiol.(1971 Jun)
  21. ^Zarcone V, Kales A, Scharf M, Tan TL, Simmons JQ, Dement WCRepeated oral ingestion of 5-hydroxytryptophan. The effect on behavior and sleep processes in two schizophrenic children.Arch Gen Psychiatry.(1973 Jun)
  22. ^Meloni M, Figorilli M, Carta M, Tamburrino L, Cannas A, Sanna F, Defazio G, Puligheddu MPreliminary finding of a randomized, double-blind, placebo-controlled, crossover study to evaluate the safety and efficacy of 5-hydroxytryptophan on REM sleep behavior disorder in Parkinson's disease.Sleep Breath.(2022 Sep)
  23. ^Bruni O, Ferri R, Miano S, Verrillo EL -5-Hydroxytryptophan treatment of sleep terrors in childrenEur J Pediatr.(2004 Jul)
  24. ^Sutanto CN, Xia X, Heng CW, Tan YS, Lee DPS, Fam J, Kim JEThe impact of 5-hydroxytryptophan supplementation on sleep quality and gut microbiota composition in older adults: A randomized controlled trial.Clin Nutr.(2024-Mar)
  25. ^Yousefzadeh F, Sahebolzamani E, Sadri A, Mortezaei A, Aqamolaei A, Mortazavi SH, Shalbafan MR, Ghaffari S, Alikhani R, Mousavi SB, Naderi S, Shamabadi A, Jalilevand S, Akhondzadeh S5-Hydroxytryptophan as adjuvant therapy in treatment of moderate to severe obsessive-compulsive disorder: a double-blind randomized trial with placebo control.Int Clin Psychopharmacol.(2020 Sep)
  26. ^Birdsall TC5-Hydroxytryptophan: a clinically-effective serotonin precursor.Altern Med Rev.(1998-Aug)
  27. ^Truyens M, Lobatón T, Ferrante M, Bossuyt P, Vermeire S, Pouillon L, Dewint P, Cremer A, Peeters H, Lambrecht G, Louis E, Rahier JF, Dewit O, Muls V, Holvoet T, Vandermeulen L, Peeters A, Gonzales GB, Bos S, Laukens D, De Vos MEffect of 5-Hydroxytryptophan on Fatigue in Quiescent Inflammatory Bowel Disease: A Randomized Controlled Trial.Gastroenterology.(2022-Aug-06)
  28. ^Lowe SL, Yeo KP, Teng L, Soon DK, Pan A, Wise SD, Peck RWL-5-Hydroxytryptophan augments the neuroendocrine response to a SSRI.Psychoneuroendocrinology.(2006 May)
  29. ^Meltzer H, Bastani B, Jayathilake K, Maes MFluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.Neuropsychopharmacology.(1997 Jul)
  30. ^Harm J Gijsman, Joop M A van Gerven, Marieke L de Kam, Rik C Schoemaker, Monique S M Pieters, Margo Weemaes, Roel de Rijk, Jeroen van der Post, Adam F CohenPlacebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteersJ Clin Psychopharmacol.(2002 Apr)
  31. ^Magnussen I, Jensen TS, Rand JH, Van Woert MHPlasma accumulation of metabolism of orally administered single dose L-5-hydroxytryptophan in man.Acta Pharmacol Toxicol (Copenh).(1981 Sep)
  32. ^Michelson D, Page SW, Casey R, Trucksess MW, Love LA, Milstien S, Wilson C, Massaquoi SG, Crofford LJ, Hallett MAn eosinophilia-myalgia syndrome related disorder associated with exposure to L-5-hydroxytryptophan.J Rheumatol.(1994-Dec)
  33. ^Sternberg EM, Van Woert MH, Young SN, Magnussen I, Baker H, Gauthier S, Osterland CKDevelopment of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.N Engl J Med.(1980 Oct 2)
Examine Database References
  1. Weight - Ceci F, Cangiano C, Cairella M, Cascino A, Del Ben M, Muscaritoli M, Sibilia L, Rossi Fanelli FThe effects of oral 5-hydroxytryptophan administration on feeding behavior in obese adult female subjectsJ Neural Transm.(1989)
  2. Weight - Cangiano C, Ceci F, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Antonucci F, Rossi-Fanelli FEating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophanAm J Clin Nutr.(1992 Nov)
  3. Sleep Terrors - Bruni O, Ferri R, Miano S, Verrillo EL -5-Hydroxytryptophan treatment of sleep terrors in childrenEur J Pediatr.(2004 Jul)
  4. Appetite - Cangiano C, Laviano A, Del Ben M, Preziosa I, Angelico F, Cascino A, Rossi-Fanelli FEffects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patientsInt J Obes Relat Metab Disord.(1998 Jul)
  5. Cortisol - Schruers K, van Diest R, Nicolson N, Griez EL-5-hydroxytryptophan induced increase in salivary cortisol in panic disorder patients and healthy volunteersPsychopharmacology (Berl).(2002 Jun)
  6. Depression Symptoms - Jangid P, Malik P, Singh P, Sharma M, Gulia AKComparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode.Asian J Psychiatr.(2013-Feb)
  7. Depression Symptoms - Pöldinger W, Calanchini B, Schwarz WA functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.Psychopathology.(1991)
  8. Depression Symptoms - Meloni M, Puligheddu M, Carta M, Cannas A, Figorilli M, Defazio GEfficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson's disease: a preliminary finding.Eur J Neurol.(2020 May)